Key result
Low-level tragus stimulation reduces postural tachycardia and improves heart rate variability in post-COVID-19 POTS.
Why the study?
Postural orthostatic tachycardia syndrome is frequently observed in post-COVID conditions, and the potential therapeutic benefits of low-level tragus stimulation had not been explored.
Does low-level tragus stimulation attenuate postural tachycardia and improve autonomic balance compared with sham stimulation in patients with POTS following COVID-19 infection?
RCT (n=57)
Web-based randomization table
Yes
Does low-level tragus stimulation attenuate postural tachycardia and improve autonomic balance compared with sham stimulation in patients with POTS following COVID-19 infection?
One month of non-invasive low-level tragus stimulation durably attenuated postural tachycardia, improved heart rate variability, and lowered sympathetic neuropeptide Y levels up to 1 year in patients with post-COVID-19 POTS.
Answers are grounded in this paper and cite their sources.
Supports low-level tragus stimulation for post-COVID POTS; extends neuromodulation evidence to post-viral autonomic recovery.
BACKGROUND: Postural orthostatic tachycardia syndrome (POTS) is characterized by symptoms of orthostatic intolerance and is frequently observed in post-COVID conditions. OBJECTIVES: We conducted controlled, prospective, and randomized clinical trials to explore the potential therapeutic benefits of low-level tragus stimulation (LL-TS) in patients with POTS following COVID-19 infection. METHODS: This study enrolled 57 participants with confirmed post-acute COVID-19 who had been diagnosed with POTS. The ear clip was attached to the right tragus of the patients for stimulation (20 Hz with a 1-ms duration) or sham stimulation. They were divided into two groups: the sham LL-TS group (sham stimulation, n = 26) and the LL-TS group (stimulation for 1 month, n = 31). LL-TS was performed 1 h twice daily for 1 month. Postural tachycardia was evaluated at baseline, 1-month visit, and 1-year visit. Heart rate variability (HRV) and plasma neuropeptide Y (NPY) were evaluated at respective time points. RESULTS: The mean age of participants was 31.9 ± 7.2 years (61.4% female). LL-TS significantly attenuated the increase in heart rate from supine to a 10-min stand, as well as the average and maximum heart rates after 1 month of treatment. LL-TS also significantly reduced NPY levels. In addition, LL-TS significantly increased the high frequency (HF), but decreased the low frequency (LF) and LF/HF ratio during the postural test (all p < 0.01). These effects persisted during the 1-year follow-up. CONCLUSION: LL-TS may be a promising therapeutic approach for attenuating autonomic imbalance in patients with POTS following COVID-19 infection.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2025) conducted an RCT in Postural orthostatic tachycardia syndrome (POTS) following COVID-19 infection (n=57). Low-level tragus stimulation (LL-TS) vs. Sham stimulation via ear clip attached to the right-sided tragus was evaluated on Increase in heart rate (ΔHR) from 25-min supine rest to 10-min standing during postural test at 1 month and 1 year (p=<0.05). Low-level tragus stimulation attenuated the postural heart rate increase, reduced plasma neuropeptide Y, and improved heart rate variability vs sham in post-COVID-19 POTS.
Synapse has enriched 10 related papers. Consider them for comparative context: